2Tempera G,Bonfiglio G,Cammarata E,et al.Microbiological/clinical characteristics and validation of topical therapy with kanamycin in aerobic vaginitis:a pilot study.Inter J Antimicrob Agents,2004,24(1):85-88.
3Nugent RP,Krohn MA,Hillier SL.Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.Journal of clinical microbiology,1991,29(2):297-301.
4Hengartner MP,Passalacqua S,Heim G,et al.The Post-Discharge network coordination programme:a randomized controlled trial to evaluate the efficacy of an intervention aimed at reducing rehospitalizatious and improving mental health[J].Front Psychiatry,2016,7(4):27.
5Theill L,Dudiuk C,Morano S,et al.Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argenlina[J].Rev Argent Microbiol,2016,48(1):43-49.
6Nash EE,Peters BM,Lilly EA,et al.A murine model of Candida glabrata vaginitis shows no evidence of an inflammatory immunopathogenic response[J].PLoS One,2016,11(1):e0147969.
8Aznar-Marin P,Galan-Sanchez F,Marin-Casanova P,et al.Candida nivariensis as a new emergent agent of vulvovaginal candidiasis:description of cases and review of published studies[J].Mycopathologia,2016,181(5/6):445-449.
9Ugwa EA.Vulvovaginal candidiasis in aminu Kano teaching hospital,North-West Nigeria:Hospital-Based epidemiological study[J].Ann Med Health Sci Res,2015,5(4):274-278.
